Dymicron is a pioneering medical technology company focused on transforming the field of musculoskeletal health. At the core of our innovation is Adymite, a polycrystalline diamond material—one of the strongest and most wear-resistant materials known to man. Adymite is a proprietary, patented material. Dymicron is the only company authorized to use PCD in all human interbody applications.
Our proprietary Adymite material offers exceptional durability, wear resistance, and proven biocompatibility. When combined with advanced engineering that supports natural motion and superior kinematics, our technology sets a new standard in musculoskeletal implants. Dymicron is redefining what’s possible in orthopedic and spine care by delivering solutions that are not only stronger and longer-lasting, but also more in tune with the human body.
Since its founding in 1997, Dymicron has brought together a team of passionate experts in medical devices, material science, clinical research, and business strategy—united by a shared mission to revolutionize musculoskeletal care. Backed by deep experience and advanced manufacturing capabilities, Dymicron is uniquely positioned to bring its breakthrough technologies to market.
Our flagship product, Triadyme®-C, is a next-generation cervical total disc replacement (cTDR) designed to dramatically improve outcomes in spine surgery. With CE Mark approval secured, Triadyme-C is now poised for international expansion, with U.S. FDA Premarket Approval (PMA) and domestic commercialization on the horizon.
Looking ahead, Dymicron plans to expand its product line with innovative devices for additional orthopedic applications—all built on the strength, durability, and biocompatibility of its proprietary Adymite material. As these next-generation solutions enter the market, Dymicron is positioned to become a global leader in orthopedic implant technology.
Bill J. Pope, PhD.
Dymicron was founded in 1997 by Dr. Bill J. Pope, a seasoned entrepreneur and professor of Chemical Engineering at Brigham Young University. With a proven track record in building successful synthetic diamond companies, Dr. Pope brought deep scientific expertise and entrepreneurial acumen to the creation of Dymicron. Recognizing a critical gap in orthopedic implant performance late in his career, he saw the opportunity to transform patient outcomes by applying synthetic diamond technology to joint and spinal disc replacement.
Driven by both business foresight and a commitment to meaningful innovation, Dr. Pope laid the foundation for Dymicron’s long-term leadership in the orthopedic and spine device industries.
Sign up to discover the latest news about Dymicron and our proprietary polycrystalline diamond technology–Adymite. Adymite is redefining performance and reliability in spinal disc replacement, including delivering unmatched durability and excellent long-term outcomes for patients.